MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
ConditionLimb Girdle Muscular Dystrophy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorRigshospitalet, Denmark
About this trial
A large cohort of MRI scans from patients with pathogenic variants in the anoctamin 5 gene will be collected through an international collaboration to better describe muscle involvement.
Eligibility criteria
Qualifiers
Two pathogenic variants in the anoctamin-5 gene
T1-weighted MR-images of lower back and leg muscles.
Disqualifiers
None
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov